Literature DB >> 12684084

Nitric oxide inhibition of free radical-mediated lipid peroxidation in photodynamically treated membranes and cells.

Magdalena Niziolek1, Witold Korytowski, Albert W Girotti.   

Abstract

Of the numerous biological activities attributed to nitric oxide ((*)NO), relatively little is known about its ability to intercept lipid-derived free radicals and thus protect cells against the damaging effects of lipid peroxidation, particularly in photodynamic settings. To address this, we asked how the (*)NO donor spermine-NONOate (SPER/NO) would affect porphyrin (PpIX)-photosensitized, iron/ascorbate-amplified chain peroxidation in cholesterol (Ch)/phospholipid (0.8:1.0, mol/mol) liposomes. Several Ch oxidation products (ChOX) were monitored by high performance chromatographic techniques. When added immediately before irradiation, SPER/NO (0.4 mM) had no effect on accumulation of 5alpha-hydroperoxide, a primary singlet oxygen-derived ChOX, but strongly suppressed the secondary species arising from postphotooxidation chain reactions, including 7alpha/7beta-hydroperoxides, 7alpha/7beta-hydroxides, and 5,6-epoxides. Metabolism of exogenous 5-aminolevulinate to PpIX in COH-BR1 tumor cells sensitized them to ChOX photogeneration and necrotic photokilling. When present during irradiation, active (but not decomposed) SPER/NO strongly inhibited both effects. These findings support the hypothesis that suitably presented NO, by intercepting lipid-derived radicals, can antagonize the antitumor effects of photodynamic therapy and other oxidative therapies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684084     DOI: 10.1016/s0891-5849(03)00026-1

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

1.  Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.

Authors:  Jonathan M Fahey; Albert W Girotti
Journal:  Nitric Oxide       Date:  2016-12-19       Impact factor: 4.427

Review 2.  Nanomedicine associated with photodynamic therapy for glioblastoma treatment.

Authors:  Leonardo B de Paula; Fernando L Primo; Antonio C Tedesco
Journal:  Biophys Rev       Date:  2017-08-19

3.  Role of Endogenous Nitric Oxide in Hyperaggressiveness of Tumor Cells that Survive a Photodynamic Therapy Challenge.

Authors:  Albert W Girotti
Journal:  Crit Rev Oncog       Date:  2016

Review 4.  Nitric Oxide-Mediated Resistance to Antitumor Photodynamic Therapy.

Authors:  Albert W Girotti
Journal:  Photochem Photobiol       Date:  2019-11-07       Impact factor: 3.421

5.  Cholesterol as a natural probe for free radical-mediated lipid peroxidation in biological membranes and lipoproteins.

Authors:  Albert W Girotti; Witold Korytowski
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-12-28       Impact factor: 3.205

Review 6.  Upregulation of pro-tumor nitric oxide by anti-tumor photodynamic therapy.

Authors:  Albert W Girotti; Jonathan M Fahey
Journal:  Biochem Pharmacol       Date:  2019-12-11       Impact factor: 5.858

7.  Subacute zinc administration and L-NAME caused an increase of NO, zinc, lipoperoxidation, and caspase-3 during a cerebral hypoxia-ischemia process in the rat.

Authors:  Victor Manuel Blanco-Alvarez; Patricia Lopez-Moreno; Guadalupe Soto-Rodriguez; Daniel Martinez-Fong; Hector Rubio; Juan Antonio Gonzalez-Barrios; Celia Piña-Leyva; Maricela Torres-Soto; María de Jesus Gomez-Villalobos; Daniel Hernandez-Baltazar; Eduardo Brambila; José Ramon Eguibar; Araceli Ugarte; Jorge Cebada; Bertha Alicia Leon-Chavez
Journal:  Oxid Med Cell Longev       Date:  2013-08-07       Impact factor: 6.543

Review 8.  Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide.

Authors:  Albert W Girotti
Journal:  Cancers (Basel)       Date:  2016-10-20       Impact factor: 6.639

Review 9.  Photodynamic Therapy as an Oxidative Anti-Tumor Modality: Negative Effects of Nitric Oxide on Treatment Efficacy.

Authors:  Albert W Girotti; Jonathan M Fahey; Mladen Korbelik
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.